INTEGRATED BIOPHARMA INC INBP
$0.17
+4.71%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | FORM 8-K PNC FIRST AMENDMENT | 2026-07-02 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-25 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-25 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-25 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-25 | View → |
| 8-K | FORM 8-K | 2026-05-08 | View → |
| 10-Q | FORM 10-Q | 2026-05-08 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-17 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-17 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-17 | View → |
| 8-K | FORM 8-K | 2026-04-15 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-26 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-25 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-25 | View → |
| 8-K | FORM 8-K | 2026-02-18 | View → |
| 8-K | FORM 8-K | 2026-02-11 | View → |
| 10-Q | FORM 10-Q | 2026-02-11 | View → |
| 4 | PRIMARY DOCUMENT | 2025-12-10 | View → |
| 4 | PRIMARY DOCUMENT | 2025-12-10 | View → |
| 4 | PRIMARY DOCUMENT | 2025-12-10 | View → |
| 8-K | FORM 8-K | 2025-12-01 | View → |
| 8-K | FORM 8-K | 2025-11-10 | View → |
| 10-Q | FORM 10-Q | 2025-11-10 | View → |
| DEF 14A | FORM DEF 14A | 2025-10-28 | View → |
| 8-K | FORM 8-K | 2025-09-23 | View → |
| 10-K | FORM 10-K | 2025-09-23 | View → |
| 4 | PRIMARY DOCUMENT | 2025-06-20 | View → |
| 4 | PRIMARY DOCUMENT | 2025-06-20 | View → |
| 4 | PRIMARY DOCUMENT | 2025-06-20 | View → |
| 4 | PRIMARY DOCUMENT | 2025-06-20 | View → |
| 4 | PRIMARY DOCUMENT | 2025-05-30 | View → |
| 4 | PRIMARY DOCUMENT | 2025-05-22 | View → |
| 4 | PRIMARY DOCUMENT | 2025-05-22 | View → |
| 4 | PRIMARY DOCUMENT | 2025-05-22 | View → |
| 4 | PRIMARY DOCUMENT | 2025-05-22 | View → |
| 8-K | FORM 8-K | 2025-05-14 | View → |
| 10-Q | FORM 10-Q | 2025-05-14 | View → |
| 8-K | FORM 8-K | 2025-04-24 | View → |
| 8-K | FORM 8-K | 2025-04-21 | View → |
| 8-K | FORM 8-K | 2025-02-13 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $0.17
- Market Cap
- —
- 52-Week Range
- $0.14 – $0.42
- Average Volume
- 8K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.